DocGo (DCGO) vs LifeMD (LFMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
LifeMD (LFMD) has outperformed DocGo (DCGO) over the past year, losing 62.5% versus a loss of 81.9%. Over five years, LFMD leads with a -65.9% price change compared with -97.7% for DCGO. LifeMD is the larger company by market cap ($69.8 million vs $17.3 million), about 4.0 times the size.
On valuation, LifeMD trades at a lower forward P/E (9.3x vs 34.7x for DocGo). LifeMD converts more of its revenue into profit, with a net margin of 7.4% versus -56.6%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DCGO | LFMD |
|---|---|---|
| Share price | $0.175 | $1.45 |
| Market cap | $17.32M | $69.84M |
| 1-day change | +1.98% | -9.40% |
| YTD return | -80.07% | -57.62% |
| 1-year return | -81.92% | -62.47% |
| 5-year return | -97.71% | -65.92% |
| Forward P/E | 34.75 | 9.32 |
| EPS (TTM) | $-1.83 | $-0.52 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $322.20M | $194.06M |
| Revenue growth (YoY) | -47.74% | +25.34% |
| Net income (latest FY) | $-182.40M | $14.35M |
| Gross margin | — | 85.72% |
| Operating margin | -55.26% | -3.95% |
| Net margin | -56.61% | 7.40% |
| 52-week high | $1.10 | $5.38 |
| 52-week low | $0.167 | $1.38 |
| Distance from 52-week high | -84.09% | -73.14% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +974.29% | +462.63% |
| Average volume | 729.51K | 929.40K |
| Shares outstanding | 98.99M | 48.33M |
| Employees | 2,537 | 347 |
| Sector | Health Care | Health Care |
| Industry | Medical/Nursing Services | Medical/Nursing Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- LifeMD is about 4.0 times larger than DocGo by market value ($69.84M vs $17.32M).
- LFMD has outperformed DCGO by 19.5 percentage points over the past year.
- LifeMD is more profitable, keeping 7.4 cents of every revenue dollar as net income versus -56.6 cents for DocGo.
- LifeMD grew revenue faster in its latest fiscal year (+25.34% vs -47.74%).
About DocGo
DCGO stock →DocGo Inc. operates as a mobile healthcare services company in the United States and the United Kingdom.
Health Care · Medical/Nursing Services · 2,537 employees
About LifeMD
LFMD stock →LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States.
Health Care · Medical/Nursing Services · 347 employees
DCGO vs LFMD FAQ
Which is bigger, DocGo or LifeMD?
LifeMD (LFMD) is larger, with a market capitalization of $69.84M compared with $17.32M for DocGo (DCGO).
Which stock has performed better over the past year, DCGO or LFMD?
LFMD returned -62.47% over the past 12 months, compared with -81.92% for DCGO (price return, excluding dividends). Past performance does not predict future results.
Are DocGo and LifeMD in the same industry?
Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.